Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
| Bayer Pharma AG,, Bayer AG, and Janssen Pharmaceuticals, Inc. |
| Mylan Pharmaceuticals Inc. and Mylan Inc. |
| 1:2022cv00063 |
| August 5, 2022 |
| US District Court for the Northern District of West Virginia |
| John Preston Bailey |
| Thomas S Kleeh |
| Patent - Abbreviated New Drug Applications (ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 21, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 32 CERTIFIED COPY OF JPML CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) - 1 action(s) re: pldg. ( #29 in MDL No. 3017, 1 in WVN/1:22-cv-00063) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 9/21/2022. Associated Cases: MDL No. 3017, WVN/1:22-cv-00063. (dk) |
| Case transferred to District of District of Delaware re MDL 3017. Entire Case file electronically transmitted. (dk) |
| Case Transfer Complete - Case transferred to District of Delaware on 9/21/2022. District of Delaware's case number is 1:22cv01228. (dk) |
| Filing 31 VERIFICATION OF ATTORNEY ADMISSION to Attorneys Wendy L. Devine, Elham F. Steiner, and Ty W. Callahan. (dk) |
Filing 29
ORDER. The motion (Doc. 28) is GRANTED. The Clerk is hereby DIRECTED to FILE the attached Exhibit 3 to the previously-filed Defendants' Motion to Dismiss (Doc. 25) UNDER SEAL. Signed by District Judge John Preston Bailey on 9/14/2022. (dk)
|
| Filing 27 Corporate Disclosure Statement by Mylan Inc., Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc.; Corporate Parent Viatris Inc. for Mylan Inc... (Copland, Gordon) |
| Filing 26 ANSWER to #1 Complaint , COUNTERCLAIM by Mylan Pharmaceuticals Inc. against All Plaintiffs by Mylan Pharmaceuticals Inc., Mylan Inc..(Copland, Gordon) |
| Filing 25 MOTION to Dismiss by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: #1 Exhibit Ex. 1, #2 Exhibit Ex. 2, #3 Exhibit Ex. 3)(Copland, Gordon) |
| Filing 24 SUMMONS Returned Executed by Secretary of State as to Mylan Inc. Served on 8/22/2022. (jb) |
| Filing 23 SUMMONS Returned Executed by Secretary of State as to Mylan Pharmaceuticals Inc. Served on 8/22/2022. (jb) |
|
Filing 22
ORDER granting #20 Motion of Kathryn S. Kayali for Leave to Appear Pro Hac Vice on behalf of Bayer AG, Bayer Pharma AG. Signed by District Judge John Preston Bailey on 8/22/2022. (dk)
|
| Filing 21 Pro Hac Vice Filing fee: $ 200.00, receipt number WVNC003497 for Attorney Kathryn S. Kayali. (jmm) |
| Filing 20 MOTION for Leave to Appear Pro Hac Vice Kathryn S. Kayali by Bayer AG,, Bayer Pharma AG,. (Attachments: #1 Proposed Order)(Taylor, Chad) |
|
Filing 19
ORDER granting #15 Motion for Leave to Appear Pro Hac Vice of Dov Grossman filed by Bayer AG and Bayer Pharma AG. Signed by District Judge John Preston Bailey on 8/17/2022. (jb)
|
| Filing 18 Filing fee for Pro Hac Vice of D. Grossman in the amount of $ 200.00. Receipt Number WVNC003494. (jb) |
|
Filing 17
ORDER granting #13 Motion for Leave to Appear Pro Hac Vice for Thomas Rein file by Janssen Pharmaceuticals, Inc. Signed by District Judge John Preston Bailey on 8/16/2022. (copy counsel of record)(jmm)
|
|
Filing 16
ORDER granting #12 Motion for Leave to Appear Pro Hac Vice for Andrew T. Langford filed by Janssen Pharmaceuticals, Inc. Signed by District Judge John Preston Bailey on 8/16/2022. (Copy counsel of record)(jmm)
|
| Filing 15 MOTION for Leave to Appear Pro Hac Vice of Dov Grossman by Bayer AG,, Bayer Pharma AG,. (Attachments: #1 Proposed Order)(Taylor, Chad) |
| Filing 14 Pro Hac Vice Filing fee: $ 400.00, receipt number WVNC003493 for Attorney Andrew T. Langford, Thomas Rein. (jmm) |
| Filing 13 MOTION for Leave to Appear Pro Hac Vice of Thomas Rein by Janssen Pharmaceuticals, Inc.. (Attachments: #1 Proposed Order)(Taylor, Chad) |
| Filing 12 MOTION for Leave to Appear Pro Hac Vice by Andrew T. Langford by Janssen Pharmaceuticals, Inc.. (Attachments: #1 Proposed Order)(Taylor, Chad) |
|
Filing 11
ORDER granting #9 Motion for Leave to Appear Pro Hac Vice for Alexander Zolan filed by Bayer AG and Bayer Pharma AG. Signed by District Judge John Preston Bailey on 8/15/2022. (jb)
|
| Filing 10 Pro Hac Vice Filing fee: $ 200.00, receipt number WVNC003492 for A. Zolan. (jmm) |
| Filing 9 MOTION for Leave to Appear Pro Hac Vice of Alexander Zolan by Bayer AG,, Bayer Pharma AG,. (Attachments: #1 Proposed Order)(Taylor, Chad) |
|
Filing 7
ORDER REASSIGNING CASE to District Judge John Preston Bailey for all further proceedings. Chief District Judge Thomas S Kleeh no longer assigned to case. Signed by Chief District Judge Thomas S Kleeh on 8/10/2022. (dk)
|
| Filing 6 VERIFICATION OF ATTORNEY ADMISSION issued to Attorneys Andrew T. Langford and Thomas D. Rein. (jmm) |
| Filing 5 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (jmm) |
| Filing 4 VERIFICATION OF ATTORNEY ADMISSION issued to Dov P. Grossman, Alexander S. Zolan and Kathryn S. Kayali (jmm) |
| Filing 3 Corporate Disclosure Statement by Janssen Pharmaceuticals, Inc. identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc... (Taylor, Chad) |
| Filing 2 Corporate Disclosure Statement by Bayer AG,, Bayer Pharma AG, identifying Corporate Parent Bayer AG for Bayer Pharma AG,.. (Taylor, Chad) |
| Filing 1 COMPLAINT against Mylan Inc., Mylan Pharmaceuticals Inc., filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) Filing Fee $402. Receipt #AWVNDC-3525636(jmm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
